Overview
Status
Active
Registry date
2017-12-29
Share capital
5,000.00 PLN
Registered address
ul. Wały Piastowskie 1/1202b, 80-855 Gdańsk, Poland
Electronic delivery address
AE:PL-40969-14103-SSTJH-28
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 90 days for 2022).
- 202508/07/2026
- 202414/07/2025
- 202306/08/2024
- 202213/10/2023
- 202101/09/2022
- 202009/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 93.81kMedianUSD 693.60kAverageUSD 2.16m
Net profit
This companyUSD 25.57kMedianUSD 5.96kAverageUSD 184.43k
Operating costs
This companyUSD 63.09kMedianUSD 575.69kAverageUSD 1.73m
Assets
This companyUSD 47.69kMedianUSD 160.81kAverageUSD 914.00k
Industry
Public procurement
6 tenders recorded as contractor: 5 national ($606,137) and 1 EU ($15,610).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 18, 2025 | Service for effective recruitment of students for the first year of fee-paying full-time English-language studies offered at Collegium Medicum UMK in Bydgoszcz for the 2025/2026 academic year | $54,859$54,859 | Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum Im. Ludwika Rydygiera w Bydgoszczy | |
| Jul 25, 2024 | Service for the effective recruitment of students for the first year of paid full-time English-language studies conducted at Collegium Medicum UMK in Bydgoszcz for the 2024/2025 academic year | $143.4K$143,438 | Uniwersytet Mikołaja Kopernika w Toruniu Collegium Medicum Im. Ludwika Rydygiera w Bydgoszczy | |
| Jun 11, 2024 | Service for effective recruitment of students for uniform long-cycle master’s studies taught in English (divided into 4 lots) in the 6-year medical programme and the 5.5-year pharmacy programme. | $15,610$15,610 | Gdański Uniwersytet Medyczny |
Authorized Representatives
Mousa Behniafard – President of the Management Board
Manner of representation
Each member of the management board is authorised to make declarations and sign on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mousa Behniafard | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-01-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $4,089.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 17, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezydent Miasta Gdańsk | |
| Jul 1, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jul 1, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Intermarium Wrocławsp. z o.o. | $776,585.05 | cogitowroclaw.pl |
FAQ
The main business activity of Avicennas International Group focuses on general upper secondary schools.
The company was registered in the Polish National Court Register (KRS) on December 29, 2017.
The headquarters is located at: ul. Wały Piastowskie 1, 80-855 Gdańsk.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 93,811, representing an increase of 2.0% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 25,572, meaning the company increased its profit by 244.0%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 29,165 in 2025, representing 46% of all operating expenses.
Last updated: 2026-10-27
